(Q48631524)

13 February 2018

title

Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids (English)

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80268-4

20 November 2022

0 references

P. H. Brown

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1775677

20 November 2022

G. Blundell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1775677

20 November 2022

A. P. Greening

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1775677

20 November 2022

G. K. Crompton

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1775677

20 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1775677

20 November 2022

publication date

1 November 1991

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0954611106802684?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80268-4

https://api.elsevier.com/content/article/PII:S0954611106802684?httpAccept=text/plain

20 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0954-6111(06)80268-4

20 November 2022

1 reference

13 February 2018

volume

85

1 reference

13 February 2018

page(s)

501-510

1 reference

13 February 2018

issue

6

1 reference

13 February 2018

Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

Effects of inhaled beclomethasone dipropionate on beta 2-receptor function in the airways and adrenal responsiveness in bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

High-dose beclomethasone inhaler in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

Six-month double-blind, controlled trial of high dose, concentrated beclomethasone dipropionate in the treatment of severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

High dose inhaled budesonide in the treatment of severe steroid-dependent asthmatics. A two-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

Recovery of hypothalamo-pituitary-adrenal function in asthmatics whose oral steroids have been stopped or reduced

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

Use of spacers to facilitate inhaled corticosteroid treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2806%2980268-4

7 January 2021

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018